New York A 3676: Establishes the Sickle Cell Treatment Act
Status: REFERRED TO HEALTH (as of 2026-01-07)
State: New York · Session: 2025-2026 · Bill: A 3676
Sponsors: Alicia Hyndman, Al Taylor, Albert A. Stirpe, Angelo Santabarbara, Aron Wieder, Brian Cunningham, David Weprin, Jeffrey Dinowitz, Karines Reyes, Larinda Hooks, Maritza Davila, Noah Burroughs, Phil Steck, Rodneyse Bichotte Hermelyn
Bill Text
Bill Search and Legislative Information | New York State Assembly • • • • • • • • Skip to main content New York State Assembly Speaker Carl E. Heastie --> --> --> • Assembly Members • Legislative Info • Public Hearings • Speaker's Press • Assembly Reports • Committees & More • Bill Search Home • Laws • Legislative Calendar • Public Hearing Schedule • Assembly Calendars • Assembly Committee Agenda Javascript must be enabled to properly view this page. Bill No.: • Summary • Actions • Committee Votes • Floor Votes • Memo • Text • LFIN • Chamber Video/Transcript A03676 Summary: BILL NOA03676B   SAME ASSAME AS S01578-B   SPONSORHyndman   COSPNSRSantabarbara, Taylor, Steck, Weprin, Burroughs, Cunningham, Wieder, Davila, Reyes, Bichotte Hermelyn, Dinowitz, Hooks, Stirpe   MLTSPNSR   Add §2807-bb, amd §3331, Pub Health L   Establishes the "Sickle Cell Treatment Act" which designates sickle cell centers for excellence and outpatient treatment centers. Go to top A03676 Actions: BILL NOA03676B   01/29/2025referred to health 02/05/2025amend and recommit to health 02/05/2025print number 3676a 03/12/2025amend (t) and recommit to health 03/12/2025print number 3676b 01/07/2026referred to health Go to topA03676 Committee Votes: Go to topA03676 Floor Votes: There are no Assembly votes for this bill in this legislative session. Go to topA03676 Text: STATE OF NEW YORK ________________________________________________________________________ 3676--B 2025-2026 Regular Sessions IN ASSEMBLY January 29, 2025 ___________ Introduced by M. of A. HYNDMAN, SANTABARBARA, TAYLOR, STECK -- read once and referred to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said commit- tee -- again reported from said committee with amendments, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to establishing the "Sickle Cell Treatment Act" The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Short title. This act shall be known and may be cited as 2 the "Sickle Cell Treatment Act". 3 § 2. The public health law is amended by adding a new section 2807-bb 4 to read as follows: 5 § 2807-bb. Sickle cell centers for excellence and outpatient treatment 6 centers. 1. Centers for sickle cell care excellence. The commissioner 7 shall designate five general hospitals or hospices with a minimum of two 8 centers north of Putnam and Orange counties under article forty of this 9 chapter, upon successful application, as centers for sickle cell care 10 excellence. The designations shall be made through an application 11 designed by the department, and based on service, staffing and other 12 criteria as developed by the commissioner. The centers of excellence 13 shall provide specialized sickle cell disease care, treatment, pallia- 14 tive care, education and related services and shall conduct specialized 15 research into the care, treatment and management of sickle cell disease. 16 Designation as a center for sickle cell care excellence shall not enti- 17 tle a center to enhanced reimbursement, but may be utilized in outreach 18 and other promotional activities. Each center for sickle cell care 19 excellence shall affiliate and cooperate with major centers of higher 20 learning, including medical colleges, and life science research insti- 21 tutes in the state. The state university shall enter into appropriate 22 legal agreements to enable this cooperation. Each center for sickle cell EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD01146-06-5 A. 3676--B 2 1 care excellence shall receive five hundred thousand dollars per year 2 from the department, from amounts appropriated for that purpose, to be 3 used on sickle cell disease research. 4 2. Outpatient treatment centers. The commissioner shall designate ten 5 hospitals, distributed based on sickle cell patient population concen- 6 trations, as sickle cell outpatient treatment centers which shall 7 provide patients treatment for sickle cell disease as an outpatient. 8 Each sickle cell outpatient treatment center shall receive two hundred 9 fifty thousand dollars per year from the department, from amounts appro- 10 priated for that purpose, to be used to ensure the proper management and 11 equipping of the centers to care for sickle cell patients. 12 § 3. Subdivision 8 of section 3331 of the public health law, as added 13 by section 7-a of part D of chapter 57 of the laws of 2018, is amended 14 to read as follows: 15 8. No opioids shall be prescribed to a patient initiating or being 16 maintained on opioid treatment for pain which has lasted more than three 17
View New York A 3676 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.